Evidence map›Paper›PMID 33841814›Full record

ArticleFood science & nutrition2021

Functional beverages improve insulin resistance and hepatic steatosis modulating lysophospholipids in diet-induced obese rats.

Julio C Rubio-Rodríguez, Rosalia Reynoso-Camacho, Nuria Rocha-Guzmán, Luis M Salgado

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Julio C Rubio-RodríguezCICATA-Querétaro Instituto Politécnico Nacional Querétaro México.
Rosalia Reynoso-CamachoResearch and Graduate Studies in Food Science Faculty of Chemistry Autonomous University of Queretaro Queretaro Mexico.ORCID https://orcid.org/0000-0002-7223-0062
Nuria Rocha-GuzmánDepartamento de Ingenierías Química y Bioquímica Research Group on Functional Foods and Nutraceuticals TecNM/Instituto Tecnológico de Durango Durango México.
Luis M SalgadoCICATA-Querétaro Instituto Politécnico Nacional Querétaro México.ORCID https://orcid.org/0000-0001-7224-2218
Polytechnic University of Queretaro · MXAutonomous University of Queretaro · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypercaloric beverages increase the prevalence of insulin resistance and nonalcoholic fatty liver disease (NAFLD), diets with polyphenolic compounds improved these alterations. The study aimed to evaluate the effect of the consumption of three functional beverages (prepared with: Roselle, green tea, cinnamon, Malabar tamarind, and peppermint in different proportions) on insulin resistance and NAFLD and their relation to liver phospholipid regulation in Wistar rats fed with a high-fat and fructose (HFF) diet. The consumption of beverages showed lower liver triglycerides compared to HFF control group, being the called beverage B the successful triggering up to 30.1%. The consumption of functional beverages improved insulin resistance and decreased the abundance of LysoPC (20:2), LysoPC (16:0), LysoPC (14:0), LysoPE (18:0), LysoPC (15:0), and LysoPC (20:1), with beverage C being the one with the meaningful effect. The results indicate that the functional beverage consumption improves insulin resistance, and decrease the degree of NAFLD, these through modifications of lysophosphatidylcholines, and lipids metabolism.

Indexed as

functional beverageinsulin resistancelipids metabolismlysophospholipidsNAFLD (nonalcoholic fatty liver disease)

Identifiers

PMID33841814
PMCPMC8020945
OpenAlexW3128119497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.